Indication

Phenylketonuria

Phenylketonuria is an autosomal recessive inborn error of metabolism characterized by a deficiency in the hepatic enzyme phenylalanine hydroxylase, which converts phenylalanine into tyrosine. Read more about Phenylketonuria

13 drugs 9 manufacturers

Advertisement

Drugs that treat it

Common Phenylketonuria therapies.

Showing 1–9 of 13 drugs

Filter & compare in the drug finder →Opens the drug finder with Phenylketonuria preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Phenylketonuria.

Phenylketonuria is an autosomal recessive inborn error of metabolism characterized by a deficiency in the hepatic enzyme phenylalanine hydroxylase, which converts phenylalanine into tyrosine.

This defect leads to the systemic accumulation of phenylalanine and its metabolites in the blood and tissues, primarily impacting the central nervous system.

Typically identified during newborn screening, untreated disease manifests clinically with profound and irreversible intellectual disability, microcephaly, developmental delay, seizures, behavioral abnormalities, hypopigmentation, and a characteristic musty body odor.

Personalize your experience

Follow Phenylketonuria and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it